Free Trial

Reviva Pharmaceuticals (RVPH) Institutional Ownership

Reviva Pharmaceuticals logo
$1.57 -0.06 (-3.68%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.53 -0.04 (-2.48%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)

Current
Institutional Ownership
Percentage
63.18%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$868.93K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$1.06M
Get RVPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RVPH Institutional Buying and Selling by Quarter

Reviva Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Tang Capital Management LLC170,000$308K0.0%N/A0.508%
2/17/2025 Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396%
2/17/2025 Focus Partners Wealth60,000$109K0.0%-62.7%0.179%
2/17/2025 Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052%
2/17/2025 Ameriprise Financial Inc.46,467$84K0.0%N/A0.139%
2/14/2025 Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164%
2/14/2025 Tower Research Capital LLC TRC 26,775$48K0.0%+848.8%0.080%
2/13/2025 XTX Topco Ltd25,020$45K0.0%N/A0.075%
2/13/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042%
2/12/2025 Geode Capital Management LLC311,701$564K0.0%+11.9%0.932%
2/6/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042%
1/23/2025 EMC Capital Management44,535$81K0.0%+142.0%0.133%
1/22/2025 Drive Wealth Management LLC20,000$36K0.0%N/A0.060%
11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833%
5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588%
2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318%
1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062%
11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649%
11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547%
8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071%
7/27/2023 Virtu Financial LLC18,448$108K0.0%N/A0.090%
2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118%
2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606%
2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033%
11/7/2022 Virtu Financial LLC46,119$73K0.0%N/A0.226%
10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161%
2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364%
2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067%
11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241%
8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742%
8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122%
8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115%
8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734%
8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735%
7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108%
5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397%
5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382%
5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397%
4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162%
(Data available from 1/1/2016 forward)

RVPH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RVPH shares?

During the previous two years, 17 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Geode Capital Management LLC ($564K), Tang Capital Management LLC ($308K), and Focus Partners Wealth ($109K).Learn more on RVPH's institutional investors.

What percentage of Reviva Pharmaceuticals stock is owned by institutional investors?

63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings.

Which institutional investors have been buying Reviva Pharmaceuticals stock?

Of the 14 institutional investors that purchased Reviva Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), Geode Capital Management LLC ($75.58K), Ameriprise Financial Inc. ($46.47K), Raymond James Financial Inc. ($28K), and Vanguard Group Inc. ($26.85K).

How much institutional buying is happening at Reviva Pharmaceuticals?

Institutional investors have bought a total of 1,779,382 shares in the last 24 months. This purchase volume represents approximately $7.65M in transactions.

Which Reviva Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Armistice Capital LLC ($224K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K).

How much institutional selling is happening at Reviva Pharmaceuticals?

Institutional investors have sold a total of 811,126 shares in the last 24 months. This volume of shares sold represents approximately $2.16M in transactions.



This page (NASDAQ:RVPH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners